Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study

• Main Authors: McCann L (Author), Ozdogan H (Author), Rutkowska-Sak L (Author), Ferrandiz MA (Author), Wulffraat NM (Author), Brik R (Author), Kallinich T (Author), Erguven M (Author), Berkun Y (Author), Constantin T (Author), Quartier P (Author), Horneff G (Author), Brunner H (Author), Ruperto N (Author), Lheritier K (Author), Preiss R (Author), Tseng L (Author), Martini A (Author), Lovell DJ (Author)
• Format: Book
• Published: BMC, 2011-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.